Download Files:
Cimpuciclib
SKU
HY-112243-Get quote
Category Reference compound
Tags Cancer; Inflammation/Immunology, CDK, Cell Cycle/DNA Damage
Products Details
Product Description
– Cimpuciclib is a selective CDK4 inhibitor (IC50: 0.49 nM) that has anti-tumor activity[1].
Web ID
– HY-112243
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C30H35FN8O
References
– [1]Liu Shiqiang, et al. Preparation of benzimidazole compound as kinase inhibitor. Patent WO 2018045956.
CAS Number
– 2202767-78-8
Molecular Weight
– 542.65
SMILES
– O=C(N1CCC(CC1)NC2CC2)C3=CC=C(NC4=NC(C5=CC6=C(N=C(C)N6C(C)C)C=C5)=C(F)C=N4)N=C3C
Clinical Information
– No Development Reported
Research Area
– Cancer; Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– CDK
Isoform
– CDK4;CDK6
Pathway
– Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.